ABSTRACT
Objectives Describe infant and maternal outcomes of a national cohort of women with preterm prelabour rupture of membranes (PPROM) under 23 weeks gestation.
Design Prospective national population-based cohort study using the UK Obstetric Surveillance System (UKOSS).
Setting All 194 obstetric units in the UK.
Participants 330 women with singleton and 38 with multiple pregnancies and PPROM between 16+0 and 22+6 weeks gestation 1/9/19-28/2/21.
Main outcome measures Infant outcomes: livebirth, survival to hospital discharge and severe morbidity, defined as intraventricular haemorrhage grade 3 or 4 and/or supplemental oxygen requirement at 36 weeks postmenstrual age.
Maternal outcomes: surgery for placental removal; sepsis; admission to intensive treatment unit (ITU) and death.
Methods All data including rates of termination of pregnancy for medical reasons (TFMR) were reported. Three rates were calculated for infant outcomes: i) all TFMR excluded; ii) assuming that all TFMR and those with missing data would have died; iii) assuming that all TFMR and those with missing data would be liveborn. Rates are presented as i (ii to iii).
Results For singleton pregnancies the livebirth rate was 44% (30 to 62%), infant survival to discharge was 26% (16 to 54%) and 18% (12 to 49%) of infants survived without severe morbidity. Maternal sepsis rate was 12% for singleton and 26% for twin pregnancies. Surgery for placental removal was 20% and 14%, respectively.
Five women became severely unwell with sepsis, 2 died and a further 3 required ITU care.
Conclusions Although significant numbers of pregnancies with very early PPROM have favourable outcomes, morbidity and mortality rates in this cohort are high for mothers and infants.
These data can be used in counselling families facing PPROM prior to 23 weeks gestation and to underpin research into the complex pathologies, including sepsis, related to this condition. Currently available guidelines should be updated accordingly.
What is already known on this topic
PPROM under 23 weeks gestation is a serious pregnancy complication with high rates of morbidity for mothers and infants
Women are often advised to consider termination for medical reasons (TFMR)
Contemporary, population based, pregnancy outcomes are not available, making counselling even more difficult
What this study adds
This study identified significant maternal morbidity; 12% of women developed sepsis and 2 women (0.6%, 95%CI 0.17-2.2%) died
Conversely infant outcomes were relatively favourable; 26% of expectantly managed infants survived to hospital discharge and the potential worst-best case survival range including those that had termination for medical reasons (TFMR) was 16-54%
Understanding of these results are imperative to appropriate counselling and management of women facing this difficult complication
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: All authors received a grant from Wellbeing of Women in partnership with Little Heartbeats (Award Ref RG2241) in relation to the submitted work. MK also holds National Institute for Health Research (NIHR) and Healthcare Quality Improvement Partnership grants, and ZA also has an NIHR Infrastructure grant covering Cochrane Pregnancy Childbirth. CC is the founder, a volunteer and president of Little Heartbeats and to support Little Heartbeats she has received donations from the public and royalties for a song that she co-wrote in memory of her daughter, Sinead. LG, AC, MT and DR declare no further competing interests.
Funding Statement
This work was supported by Wellbeing of Women in partnership with Little Heartbeats (Award Ref RG2241). The views expressed are those of the authors and not necessarily those of Wellbeing of Women or Little Heartbeats. CC, the founder of Little Heartbeats, provided PPI input into the study but ultimate responsibility for the final study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication was held by the academic researchers, LG, MK and ZA. All authors had full access to all the data in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. MK is an NIHR Senior Investigator (NIHR201333). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee North London REC1 gave ethical approval for this work (Ref. Number 10/H0717/20).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data cannot be shared publicly because of confidentiality issues and potentially identifiable sensitive data as identified within the Research Ethics Committee application/approval. Requests to access the data can be made by contacting the National Perinatal Epidemiology Unit data access committee via general{at}npeu.ox.ac.uk.
